| 股號 / 名稱 | 總負債 | 淨值 |
| AZN AstraZeneca PLC | 61,976,000,000.0 | 39,143,000,000.0 |
| BMY 施貴寶 | 65,729,000,000.0 | 29,430,000,000.0 |
| REGN 雷傑納榮製藥 | 7,107,100,000.0 | 25,973,100,000.0 |
| GILD 吉利德科學 | 39,292,000,000.0 | 22,833,000,000.0 |
| VRTX 福泰製藥 | 5,149,800,000.0 | 17,580,400,000.0 |
| BIIB Biogen Inc | 12,045,400,000.0 | 14,799,400,000.0 |
| MRNA 莫德納 | 4,572,000,000.0 | 13,854,000,000.0 |
| ABBV 艾伯維 | 124,351,000,000.0 | 10,360,000,000.0 |
| BIO.B Bio Rad Laboratories Inc | 3,557,937,000.0 | 8,741,133,000.0 |
| AMGN 美國安進 | 90,922,000,000.0 | 6,232,000,000.0 |
| ROIV Roivant Sciences Ltd | 1,222,916,000.0 | 6,089,763,000.0 |
| ILMN Illumina Inc | 4,366,000,000.0 | 5,745,000,000.0 |
| INCY 英賽德 | 1,592,270,000.0 | 5,189,837,000.0 |
| BMRN Biomarin Pharmaceutical Inc | 1,890,054,000.0 | 4,951,549,000.0 |
| ARGX argenx SE | 444,951,000.0 | 4,097,507,000.0 |
| QGEN Qiagen NV | 2,307,426,000.0 | 3,807,764,000.0 |
| BGNE Beigene Ltd | 2,267,948,000.0 | 3,537,327,000.0 |
| EXAS Exact Sciences Corp | 3,326,029,000.0 | 3,145,305,000.0 |
| EXEL Exelixis Inc | 678,445,000.0 | 2,263,912,000.0 |
| RGEN Repligen Corp | 853,208,000.0 | 1,971,203,000.0 |
| TECH Bio-Techne Corp | 767,194,000.0 | 1,963,559,000.0 |
| CRSP CRISPR Therapeutics AG | 346,768,000.0 | 1,882,803,000.0 |
| VIR Vir Biotechnology Inc | 328,824,000.0 | 1,590,236,000.0 |
| LEGN Legend Biotech Corp | 597,238,000.0 | 1,251,371,000.0 |
| PCVX Vaxcyte Inc | 167,449,000.0 | 1,240,468,000.0 |
| ALKS Alkermes Plc | 933,537,000.0 | 1,202,686,000.0 |
| ABCL Abcellera Biologics Inc | 335,776,000.0 | 1,152,318,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 568,190,000.0 | 1,097,152,000.0 |
| CERT Certara Inc | 516,300,000.0 | 1,046,840,000.0 |
| DNLI Denali Therapeutics Inc | 122,963,000.0 | 1,030,954,000.0 |
| BEAM Beam Therapeutics Inc | 478,385,000.0 | 981,329,000.0 |
| NEO Neogenomics Inc | 739,692,000.0 | 941,537,000.0 |
| XENE Xenon Pharmaceuticals Inc | 36,877,000.0 | 927,921,000.0 |
| SRPT Sarepta Therapeutics Inc | 2,405,239,000.0 | 859,337,000.0 |
| ZLAB Zai Lab Ltd | 240,177,000.0 | 796,118,000.0 |
| MYGN Myriad Genetics Inc | 363,300,000.0 | 783,200,000.0 |
| KRYS Krystal Biotech Inc | 39,714,000.0 | 778,641,000.0 |
| HCM HUTCHMED (China) Ltd | 549,232,000.0 | 730,541,000.0 |
| LGND Ligand Pharmaceuticals Inc | 86,303,000.0 | 700,913,000.0 |
| NUVL Nuvalent Inc | 31,823,000.0 | 700,561,000.0 |
| MORF Morphic Holding Inc | 25,492,000.0 | 697,022,000.0 |
| IMVT Immunovant Inc | 32,102,000.0 | 679,344,000.0 |
| ARVN Arvinas Inc | 644,600,000.0 | 660,000,000.0 |
| EBS Emergent BioSolutions Inc | 1,173,900,000.0 | 649,300,000.0 |
| SWTX SpringWorks Therapeutics Inc | 99,569,000.0 | 626,219,000.0 |
| DVAX Dynavax Technologies Corp | 375,024,000.0 | 622,072,000.0 |
| IDYA IDEAYA Biosciences Inc | 28,226,000.0 | 621,090,000.0 |
| NUVB Nuvation Bio Inc | 16,362,000.0 | 605,122,000.0 |
| ITCI Intra-Cellular Therapies Inc | 136,871,000.0 | 591,424,000.0 |
| TWST Twist Bioscience Corp | 142,773,000.0 | 590,042,000.0 |
| IOVA Iovance Biotherapeutics Inc | 195,738,000.0 | 584,613,000.0 |
| ITOS Iteos Therapeutics Inc | 92,360,000.0 | 575,228,000.0 |
| PRTA Prothena Corporation PLC | 135,017,000.0 | 561,365,000.0 |
| AVIR Atea Pharmaceuticals Inc | 39,776,000.0 | 555,192,000.0 |
| SNDX Syndax Pharmaceuticals Inc | 58,684,000.0 | 554,196,000.0 |
| AMRN Amarin Corporation PLC | 279,587,000.0 | 552,097,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 103,530,000.0 | 544,910,000.0 |
| ETNB 89Bio Inc | 59,963,000.0 | 536,306,000.0 |
| AKRO Akero Therapeutics Inc | 44,965,000.0 | 535,306,000.0 |
| MESO Mesoblast Ltd | 161,554,000.0 | 508,731,000.0 |
| RNA Avidity Biosciences Inc | 127,791,000.0 | 500,764,000.0 |
| RCKT Rocket Pharmaceuticals Inc | 73,767,000.0 | 492,574,000.0 |
| ACLX Arcellx Inc | 339,752,000.0 | 485,380,000.0 |
| PLRX Pliant Therapeutics Inc | 38,578,000.0 | 473,576,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 344,456,000.0 | 466,992,000.0 |
| ZYME Zymeworks Inc | 116,074,000.0 | 464,806,000.0 |
| RCUS Arcus Biosciences Inc | 633,000,000.0 | 462,000,000.0 |
| ANIP ANI Pharmaceuticals Inc | 446,823,000.0 | 457,599,000.0 |
| CGEM Cullinan Therapeutics Inc | 30,479,000.0 | 453,703,000.0 |
| VRDN Viridian Therapeutics Inc | 48,402,000.0 | 442,022,000.0 |
| KNSA Kiniksa Pharmaceuticals Ltd | 87,483,000.0 | 438,839,000.0 |
| ZNTL Zentalis Pharmaceuticals Inc | 114,404,000.0 | 437,284,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 317,201,000.0 | 431,755,000.0 |
| CLDX Celldex Therapeutics Inc | 36,456,000.0 | 429,171,000.0 |
| BHVN Biohaven Ltd | 85,237,000.0 | 427,975,000.0 |
| REPL Replimune Group Inc | 111,393,000.0 | 421,537,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 1,070,697,000.0 | 416,753,000.0 |
| KURA Kura Oncology Inc | 51,662,000.0 | 397,273,000.0 |
| SEER Seer Inc | 39,365,000.0 | 396,904,000.0 |
| KYMR Kymera Therapeutics Inc | 180,788,000.0 | 394,971,000.0 |
| CTKB Cytek Biosciences Inc | 101,393,000.0 | 393,064,000.0 |
| CSTL Castle Biosciences Inc | 62,071,000.0 | 391,269,000.0 |
| ME 23andMe Holding Co. | 231,023,000.0 | 377,188,000.0 |
| BCYC Bicycle Therapeutics PLC | 224,412,000.0 | 370,932,000.0 |
| FATE Fate Therapeutics Inc | 137,800,000.0 | 368,417,000.0 |
| CRBU Caribou Biosciences Inc | 63,808,000.0 | 368,401,000.0 |
| MRUS Merus NV | 99,151,000.0 | 356,343,000.0 |
| DCPH Deciphera Pharmaceuticals Inc | 122,650,000.0 | 350,916,000.0 |
| EDIT Editas Medicine Inc | 150,056,000.0 | 349,097,000.0 |
| VKTX Viking Therapeutics Inc | 20,071,000.0 | 348,419,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 29,508,000.0 | 346,540,000.0 |
| JANX Janux Therapeutics Inc | 36,058,000.0 | 344,349,000.0 |
| PTGX Protagonist Therapeutics Inc | 21,274,000.0 | 336,677,000.0 |
| KROS Keros Therapeutics Inc | 37,812,000.0 | 332,213,000.0 |
| EWTX Edgewise Therapeutics Inc | 21,205,000.0 | 318,830,000.0 |
| ERAS Erasca Inc | 78,611,000.0 | 316,686,000.0 |
| RGNX Regenxbio Inc | 262,228,000.0 | 311,742,000.0 |
| ADPT Adaptive Biotechnologies Corp | 352,735,000.0 | 308,399,000.0 |
| SANA Sana Biotechnology Inc | 277,793,000.0 | 287,506,000.0 |
| ARCT Arcturus Therapeutics Holdings Inc | 150,889,000.0 | 278,513,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例